Ferring would like to use cookies to better understand your use of this website and improve your experience on our website. Please accept our use of cookies in accordance of our privacy policy

Press releases

New website about primary nocturnal enuresis opened in Scandinavia

Copenhagen, Denmark
3 March 2003

Ferring Pharmaceuticals is proud to announce the launch of the website www.dryallnight.com

The site is available in the Scandinavian languages, Danish, Norwegian, Swedish and Finnish and is intended to function as a one-stop information resource for parents, teachers and health professionals with respect to primary nocturnal enuresis (bedwetting). The information on the site is based on knowledge from leading Scandinavian groups with enuresis expertise.

Over 200.000 Scandinavian children have problems with bedwetting. The goal of the site is to create awareness that bedwetting is a common problem which can be treated promptly and effectively.


Ferring is a research driven, speciality biopharmaceutical group active in global markets.  The company identifies, develops and markets innovative products in the areas of urology, obstetrics and infertility, gastroenterology and endocrinology.  In recent years Ferring has expanded beyond its traditional European base and now has operating subsidiaries in over 40 countries.

To learn more about Ferring or our products  please visit us at www.Ferring.com

For more information, please contact:
Karsten Lauridsen
Ferring Lægemidler
Telephone: + 45 28 95 96 22
Email: karsten.lauridsen@ferring.com

See more Press releases

Headquarters

FERRING INTERNATIONAL CENTER S.A.
CH. DE LA VERGOGNAUSAZ 50
1162 SAINT-PREX
SWITZERLAND

TEL:  +41 58 301 00 00
FAX: +41 58 301 00 10

CONTACT

Global Locator